Cargando…

Retraction: Does changing from a first generation antipsychotic (perphenazin) to a second generation antipsychotic (risperidone) alter brain activation and motor activity? A case report

Detalles Bibliográficos
Autores principales: Berle, Jan Øystein, Løberg, Else-Marie, Fasmer, Ole Bernt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3844366/
https://www.ncbi.nlm.nih.gov/pubmed/23962164
http://dx.doi.org/10.1186/1756-0500-6-332
_version_ 1782293167025946624
author Berle, Jan Øystein
Løberg, Else-Marie
Fasmer, Ole Bernt
author_facet Berle, Jan Øystein
Løberg, Else-Marie
Fasmer, Ole Bernt
author_sort Berle, Jan Øystein
collection PubMed
description
format Online
Article
Text
id pubmed-3844366
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38443662013-12-02 Retraction: Does changing from a first generation antipsychotic (perphenazin) to a second generation antipsychotic (risperidone) alter brain activation and motor activity? A case report Berle, Jan Øystein Løberg, Else-Marie Fasmer, Ole Bernt BMC Res Notes Retraction BioMed Central 2013-08-20 /pmc/articles/PMC3844366/ /pubmed/23962164 http://dx.doi.org/10.1186/1756-0500-6-332 Text en Copyright © 2013 Øystein Berle et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
Berle, Jan Øystein
Løberg, Else-Marie
Fasmer, Ole Bernt
Retraction: Does changing from a first generation antipsychotic (perphenazin) to a second generation antipsychotic (risperidone) alter brain activation and motor activity? A case report
title Retraction: Does changing from a first generation antipsychotic (perphenazin) to a second generation antipsychotic (risperidone) alter brain activation and motor activity? A case report
title_full Retraction: Does changing from a first generation antipsychotic (perphenazin) to a second generation antipsychotic (risperidone) alter brain activation and motor activity? A case report
title_fullStr Retraction: Does changing from a first generation antipsychotic (perphenazin) to a second generation antipsychotic (risperidone) alter brain activation and motor activity? A case report
title_full_unstemmed Retraction: Does changing from a first generation antipsychotic (perphenazin) to a second generation antipsychotic (risperidone) alter brain activation and motor activity? A case report
title_short Retraction: Does changing from a first generation antipsychotic (perphenazin) to a second generation antipsychotic (risperidone) alter brain activation and motor activity? A case report
title_sort retraction: does changing from a first generation antipsychotic (perphenazin) to a second generation antipsychotic (risperidone) alter brain activation and motor activity? a case report
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3844366/
https://www.ncbi.nlm.nih.gov/pubmed/23962164
http://dx.doi.org/10.1186/1756-0500-6-332
work_keys_str_mv AT berlejanøystein retractiondoeschangingfromafirstgenerationantipsychoticperphenazintoasecondgenerationantipsychoticrisperidonealterbrainactivationandmotoractivityacasereport
AT løbergelsemarie retractiondoeschangingfromafirstgenerationantipsychoticperphenazintoasecondgenerationantipsychoticrisperidonealterbrainactivationandmotoractivityacasereport
AT fasmerolebernt retractiondoeschangingfromafirstgenerationantipsychoticperphenazintoasecondgenerationantipsychoticrisperidonealterbrainactivationandmotoractivityacasereport